Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
Annovis Bio, Inc. (ANVS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2023 |
4
| Maccecchini Maria-Luisa (President and CEO) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Exercised 52,755 options to buy
@ $0.14, valued at
$7.4k
|
|
| 01/20/2023 |
4
| Maccecchini Maria-Luisa (President and CEO) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 21,312 options to buy
@ $13.17, valued at
$280.7k
|
|
| 01/20/2023 |
4
| Hagopian Henry III (CFO) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 7,672 options to buy
@ $13.17, valued at
$101k
|
|
| 01/20/2023 |
4
| White Mark K. (Director) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 5,967 options to buy
@ $13.17, valued at
$78.6k
|
|
| 01/20/2023 |
4
| McCarthy Reid (Director) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 5,967 options to buy
@ $13.17, valued at
$78.6k
|
|
| 01/20/2023 |
4
| Hoffman Michael B (10% Owner) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 6,820 options to buy
@ $13.17, valued at
$89.8k
|
|
| 01/20/2023 |
4
| Bruck Claudine (Director) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 5,967 options to buy
@ $13.17, valued at
$78.6k
|
|
| 08/31/2022 |
4
| Hagopian Henry III (CFO) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 120,000 options to buy
@ $11.55, valued at
$1.4M
|
|
| 01/18/2022 |
4
| Maccecchini Maria-Luisa (President and CEO) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Exercised 32,959 options to buy
@ $0.14, valued at
$4.6k
|
|
| 01/05/2022 |
4
| White Mark K. (Director) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 8,000 options to buy
@ $19.78, valued at
$158.2k
|
|
| 01/05/2022 |
4
| McGroarty Jeffrey Brian (CFO) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 28,000 options to buy
@ $19.78, valued at
$553.8k
|
|
| 01/05/2022 |
4
| McCarthy Reid (Director) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 8,000 options to buy
@ $19.78, valued at
$158.2k
|
|
| 01/05/2022 |
4
| Maccecchini Maria-Luisa (President and CEO) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 83,400 options to buy
@ $19.78, valued at
$1.6M
Granted 19,894 options to buy
@ $19.78, valued at
$393.5k
|
|
| 01/05/2022 |
4
| Hoffman Michael B (10% Owner) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Paid exercise price by delivering 6,658 shares
@ $19.78, valued at
$131.7k
Paid exercise price by delivering 90 shares
@ $19.78, valued at
$1.8k
Granted 9,000 options to buy
@ $19.78, valued at
$178k
Exercised 30,000 options to buy
@ $4.39, valued at
$131.7k
Exercised 7,142 options to buy
@ $0.25, valued at
$1.8k
|
|
| 01/05/2022 |
4
| Bruck Claudine (Director) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 8,000 options to buy
@ $19.78, valued at
$158.2k
|
|
| 12/08/2021 |
4
| McGroarty Jeffrey Brian (CFO) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 30,396 options to buy
@ $20.97, valued at
$637.4k
Granted 165,199 options to buy
@ $20.97, valued at
$3.5M
|
|
| 12/08/2021 |
4
| Maccecchini Maria-Luisa (President and CEO) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 112,995 options to buy
@ $20.97, valued at
$2.4M
Granted 145,305 options to buy
@ $20.97, valued at
$3M
|
|
| 10/13/2021 |
4
| Bruck Claudine (Director) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Bought 181 shares
@ $27.66, valued at
$5k
|
|
| 10/13/2021 |
4
| White Mark K. (Director) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Bought 5,000 shares
@ $27.4, valued at
$137k
|
|
| 10/13/2021 |
4
| Maccecchini Maria-Luisa (PRESIDENT AND CEO) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Bought 18,000 shares
@ $27.61, valued at
$497k
|
|
| 08/23/2021 |
4
| McCarthy Reid (Director) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Bought 500 shares
@ $37.61, valued at
$18.8k
|
|
| 07/09/2021 |
4
| White Mark K. (Director) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 4,000 options to buy
@ $102.85, valued at
$411.4k
|
|
| 07/09/2021 |
4
| McGroarty Jeffrey Brian (CFO) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 14,000 options to buy
@ $102.85, valued at
$1.4M
|
|
| 07/09/2021 |
4
| McCarthy Reid (Director) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 4,000 options to buy
@ $102.85, valued at
$411.4k
|
|
| 07/09/2021 |
4
| Maccecchini Maria-Luisa (President and CEO) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 41,700 options to buy
@ $102.85, valued at
$4.3M
|
|
| 07/09/2021 |
4
| Hoffman Michael B (10% Owner) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 4,500 options to buy
@ $102.85, valued at
$462.8k
|
|
| 07/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2020 |
4
| McGroarty Jeffrey Brian (CFO) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 300,000 options to buy
@ $3.13, valued at
$939k
|
|
| 04/13/2020 |
4
| Maccecchini Maria-Luisa (President and CEO) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Granted 300,000 options to buy
@ $3.13, valued at
$939k
|
|
| 02/05/2020 |
4
| Hoffman Michael B (10% Owner) has filed a Form 4 on Annovis Bio, Inc.|
Txns:
| Bought 33,333 shares
@ $6, valued at
$200k
Converted 158,730 shares
@ $0
Converted 1,137,942 shares
@ $0
Converted 55,884 shares
@ $4.8, valued at
$268.2k
Converted 222,222 preferred shares
@ $0
Converted 1,593,118 preferred shares
@ $0
Converted 55,884 convertible notes
@ $4.8, valued at
$268.2k
|
|
|
|
|